---
$id: https://graph.org.ai/products/commodity/51422412
$type: Product
source: UNSPSC
code: "51422412"
title: "Flumedroxone"
class: "51422400"
classTitle: "Corticosteroid pregnenediones"
family: "51420000"
familyTitle: "Corticosteroids"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Flumedroxone

**UNSPSC Code**: 51422412
**Class**: [Corticosteroid pregnenediones](Corticosteroid pregnenediones.mdx)
**Family**: [Corticosteroids](../Corticosteroids.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29F3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K80185F39X, chemically known as 17-hydroxy-6alpha-(trifluoromethyl)pregn-4-ene-3,20-dione but generally known as flumedroxone, which bears US NIH Compound Identifier 71881. European Medicines Agency schedules Flumedroxone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07695MIG. The term FLUMEDROXONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules flumedroxone in its Anatomical Therapeutic Chemical (ATC) Classification. FLUMEDROXONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flumedroxone under HS 29147000 and SITC 51629. As of Q4 2014, FLUMEDROXONE remains the US FDA Preferred Term for this commodity. Flumedroxone bears US NLM identifiers UMLS ID C0060492 and NCI Concept Code C65715. SMILES: FC(F)(F)C1CC2C3C(C(O)(CC3)C(=O)C)(CCC2C2(C1=CC(=O)CC2)C)C.

